Kashiv BioSciences
Focus: Kashiv BioSciences is a newly-founded (2024) biosimilars-focused biotech company based in Piscataway, NJ with two marketed colony-stimulating factor products (FYLNETRA pegfilgrastim and RELEUKO filgrastim) in the infectious disease space. The company is entirely revenue-dependent on FYLNETRA, indicating early-stage commercial operations with limited market diversification.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
5-18 this month
Cooling — net -18 jobs in 30d
1 added, 19 removed. Slower than typical.
Should You Work at Kashiv BioSciences?
AI assessmentHigh-risk, high-reward early-stage opportunity best suited for manufacturing, supply chain, or operational professionals willing to bet career trajectory on a single commercial product and unproven management team.
Why Work Here
- Join a 2024-founded company with two FDA-approved biosimilars already at peak lifecycle stage, offering ground-floor equity and operational scaling opportunities.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$81K Part DStable
Peak
Company's sole revenue driver; biosimilar to Neulasta with limited Part D penetration suggests early commercial phase and significant upside or downside risk.
Help build intelligence for Kashiv BioSciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.